THE ABSENCE OR LOSS OF ANTIBODIES OF HIGH-AFFINITY TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IS ASSOCIATED WITH DISEASE PROGRESSION IN HIV-1-INFECTED PATIENTS

被引：17

作者：

CHARGELEGUE, D ^{[1
]}

STANLEY, CM ^{[1
]}

OTOOLE, CM ^{[1
]}

COLVIN, BT ^{[1
]}

STEWARD, MW ^{[1
]}

机构：

[1] LONDON HOSP,COLL MED,LONDON,ENGLAND

来源：

JOURNAL OF INFECTIOUS DISEASES | 1995年 / 172卷 / 03期

关键词：

D O I：

10.1093/infdis/172.3.897

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：897 / 898

页数：2

共 10 条

[1] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS WITH NO DISEASE PROGRESSION DISPLAY HIGH-AVIDITY ANTIBODY-PRODUCTION TO AUTOLOGOUS V3 SEQUENCES
BROSTROM, C
SONNERBORG, A
SALLBERG, M
[J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 509 - 511
[2] A 7-YEAR ANALYSIS OF ANTI-GAG (P17 AND P24) ANTIBODIES IN HIV-1-SEROPOSITIVE PATIENTS WITH HEMOPHILIA - IMMUNOGLOBULIN-G TITER AND AVIDITY ARE EARLY PREDICTORS OF CLINICAL COURSE
CHARGELEGUE, D
COLVIN, BT
OTOOLE, CM
[J]. AIDS, 1993, 7 : S87 - S90
[3] CHARGELEGUE D, 1995, CLIN EXP IMMUNOL, V99, P175, DOI 10.1111/j.1365-2249.1995.tb05529.x
[4] ARTIFACTS WITH THE THIOCYANATE ELUTION METHOD FOR ESTIMATING RELATIVE ANTIBODY AVIDITY
GRAY, BM
SHAW, DR
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) : 269 - 271
[5] VERTICAL TRANSMISSION OF HIV-1 - CORRELATION WITH MATERNAL VIRAL LOAD AND PLASMA-LEVELS OF CD4 BINDING-SITE ANTI-GP120 ANTIBODIES
KHOURI, YF
MCINTOSH, K
CAVACINI, L
POSNER, M
PAGANO, M
TUOMALA, R
MARASCO, WA
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) : 732 - 737
[6] MIEDEMA F, 1993, IMMUNODEFIEICNEIES, P385
[7] PROTECTION AGAINST MORBILLIVIRUS-INDUCED ENCEPHALITIS BY IMMUNIZATION WITH A RATIONALLY DESIGNED SYNTHETIC PEPTIDE VACCINE CONTAINING B-CELL AND T-CELL EPITOPES FROM THE FUSION PROTEIN OF MEASLES-VIRUS
OBEID, OE
PARTIDOS, CD
HOWARD, CR
STEWARD, MW
[J]. JOURNAL OF VIROLOGY, 1995, 69 (03) : 1420 - 1428
[8] STEWARD MW, 1991, IMMUNOLOGY, V72, P99
[9] STEWARD MW, 1986, HDB EXPT IMMUNOLOGY
[10] WEN YM, 1990, CLIN EXP IMMUNOL, V79, P83

← 1 →